📃Just published in JNM: our recent study showing the clinical value of FET PET to identify early response to Regorafenib in patients with #glioma.
🔗: jnm.snmjournals.org/content/earl...
Thanks to @galldiks.bsky.social, @ph-lohmann.bsky.social and co-authors.
#aminoacidPET #braintumor
🔗: jnm.snmjournals.org/content/earl...
Thanks to @galldiks.bsky.social, @ph-lohmann.bsky.social and co-authors.
#aminoacidPET #braintumor
January 12, 2026 at 7:05 AM
📃Just published in JNM: our recent study showing the clinical value of FET PET to identify early response to Regorafenib in patients with #glioma.
🔗: jnm.snmjournals.org/content/earl...
Thanks to @galldiks.bsky.social, @ph-lohmann.bsky.social and co-authors.
#aminoacidPET #braintumor
🔗: jnm.snmjournals.org/content/earl...
Thanks to @galldiks.bsky.social, @ph-lohmann.bsky.social and co-authors.
#aminoacidPET #braintumor
Happy to share our latest work from @galldiks.bsky.social group on the Value of Multidisciplinary Neuro-oncological Tumor Boards to increase the Accuracy of FET PET for Identifying Brain Tumor Relapse. #AminoAcidPet #Glioma #btsm #BrainMet
journals.lww.com/nuclearmed/f...
journals.lww.com/nuclearmed/f...
The Value of Multidisciplinary Neuro-oncological Tumor... : Clinical Nuclear Medicine
tyrosine (FET) PET information compared with FET PET results alone to differentiate tumor relapse from treatment-related changes.
Patients and Methods
In a single academic center, we retrospectivel...
journals.lww.com
January 14, 2025 at 11:24 AM
Happy to share our latest work from @galldiks.bsky.social group on the Value of Multidisciplinary Neuro-oncological Tumor Boards to increase the Accuracy of FET PET for Identifying Brain Tumor Relapse. #AminoAcidPet #Glioma #btsm #BrainMet
journals.lww.com/nuclearmed/f...
journals.lww.com/nuclearmed/f...